Natus Medical (BABY) Downgraded to “Sell” at BidaskClub

BidaskClub downgraded shares of Natus Medical (NASDAQ:BABY) from a hold rating to a sell rating in a research report sent to investors on Saturday morning.

Separately, Zacks Investment Research raised Natus Medical from a hold rating to a buy rating and set a $45.00 price target for the company in a report on Tuesday, October 24th. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and two have assigned a buy rating to the company. The stock presently has a consensus rating of Hold and an average price target of $46.50.

Shares of Natus Medical (BABY) traded down $0.30 during mid-day trading on Friday, hitting $37.60. The company’s stock had a trading volume of 415,693 shares, compared to its average volume of 359,540. Natus Medical has a one year low of $31.65 and a one year high of $43.60. The stock has a market cap of $1,171.39, a P/E ratio of 24.26 and a beta of 0.84. The company has a quick ratio of 3.36, a current ratio of 4.21 and a debt-to-equity ratio of 0.36.

Natus Medical (NASDAQ:BABY) last posted its quarterly earnings results on Wednesday, October 25th. The medical equipment provider reported $0.40 EPS for the quarter, beating the consensus estimate of $0.38 by $0.02. The business had revenue of $122.60 million during the quarter, compared to analysts’ expectations of $122.41 million. Natus Medical had a positive return on equity of 12.06% and a negative net margin of 0.62%. The company’s quarterly revenue was up 34.9% compared to the same quarter last year. During the same period last year, the firm earned $0.39 EPS. research analysts expect that Natus Medical will post 1.74 EPS for the current year.

In other news, Director William M. Moore sold 5,000 shares of the firm’s stock in a transaction that occurred on Monday, November 13th. The stock was sold at an average price of $41.01, for a total value of $205,050.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Robert A. Gunst sold 4,400 shares of the firm’s stock in a transaction that occurred on Thursday, September 14th. The shares were sold at an average price of $35.17, for a total value of $154,748.00. Following the completion of the sale, the director now directly owns 50,850 shares of the company’s stock, valued at $1,788,394.50. The disclosure for this sale can be found here. Insiders sold a total of 22,042 shares of company stock valued at $902,266 over the last three months. Insiders own 5.50% of the company’s stock.

Hedge funds have recently modified their holdings of the stock. Eqis Capital Management Inc. raised its holdings in Natus Medical by 25.0% during the third quarter. Eqis Capital Management Inc. now owns 16,740 shares of the medical equipment provider’s stock worth $628,000 after purchasing an additional 3,353 shares during the last quarter. Virginia Retirement Systems ET AL raised its holdings in Natus Medical by 122.3% during the second quarter. Virginia Retirement Systems ET AL now owns 26,900 shares of the medical equipment provider’s stock worth $1,003,000 after purchasing an additional 14,800 shares during the last quarter. Bank of New York Mellon Corp raised its holdings in Natus Medical by 9.7% during the second quarter. Bank of New York Mellon Corp now owns 973,346 shares of the medical equipment provider’s stock worth $36,307,000 after purchasing an additional 86,192 shares during the last quarter. Capital Management Associates NY acquired a new position in Natus Medical during the third quarter worth $412,000. Finally, Municipal Employees Retirement System of Michigan raised its holdings in Natus Medical by 3.2% during the second quarter. Municipal Employees Retirement System of Michigan now owns 7,760 shares of the medical equipment provider’s stock worth $289,000 after purchasing an additional 240 shares during the last quarter. 94.39% of the stock is owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: This story was first posted by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this story on another site, it was illegally stolen and reposted in violation of U.S. & international copyright & trademark law. The legal version of this story can be viewed at https://stocknewstimes.com/2017/12/10/natus-medical-baby-downgraded-to-sell-at-bidaskclub.html.

About Natus Medical

Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders.

Receive News & Ratings for Natus Medical Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natus Medical Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply